COMBINATION CHEMOTHERAPY WITH BIWEEKLY CETUXIMAB AND IRINOTECAN FOR WILD-TYPE KRAS METASTATIC COLORECTAL CANCER, REFRACTORY TO BOTH OXALIPLATIN AND IRINOTECAN

被引:0
作者
Barbosa, Caroline [1 ]
Sousa, Romulado [1 ]
Sabbaga, Jorge [1 ]
Cotti, Guilherme [1 ]
Saragiotto, Daniel [1 ]
Hoff, Paulo [1 ]
机构
[1] Inst Canc Estado Sao Paulo, Sao Paulo, Brazil
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:v103 / v103
页数:1
相关论文
共 1 条
[1]   Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].
Cunningham, D ;
Humblet, Y ;
Siena, S ;
Khayat, D ;
Bleiberg, H ;
Santoro, A ;
Bets, D ;
Mueser, M ;
Harstrick, A ;
Verslype, C ;
Chau, I ;
Van Cutsem, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345